Medbridge provides healthcare education and patient care software. The solutions aim to strengthen the patient-provider connection through evidence-based online continuing education and innovative tools.

Medbridge

AMBOSS provides a platform that combines learning and clinical tools for medical students and clinicians, offering resources for board exam preparation and clinical practice.

AMBOSS

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity, Inc.

MedShr focuses on medical education and physician engagement, providing a platform for case-based learning and professional development for doctors.

Metric
Company Name	Medbridge	AMBOSS	Doximity, Inc.	MedShr
Symbol			DOCS
MSH ID	COM:MEDBRIDGE	COM:AMBOSS	COM:DOXIMITY	COM:MEDSHR
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Healthcare Technology	Medical Education and Healthcare Technology	Medical - Healthcare Information Services	Medical Education
Country	US	US	US	GB
Stage			Secondary Market	Seed
Employee Count		713	827
Website	medbridge.com	amboss.com	doximity.com	medshr.com
LinkedIn		amboss-md
Founders

Metric
Market Cap	4.94B
Enterprise Value
Monthly Web Traffic	8.09M
Web Traffic Growth	0.09
Valuation
Raised Capital		1.90M

Metric
Revenue			475.42M
Revenue (LTM)
Revenue (NTM)
Gross Profit			424.75M
EBITDA			182.08M
Operating Income			171.81M
Net Income			147.58M
EPS			0.78
Diluted EPS			0.72
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.90
Operating Profit Margin			0.37
EBITDA Margin			0.38
Net Profit Margin			0.33
Return on Equity			0.18
Return on Assets			0.15
Return on Capital Employed			0.19

COM:MEDBRIDGE

Medbridge

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			42.68
P/B Ratio			6.03
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			16.75
EV Multiple			40.46

Metric
Days Sales Outstanding			79.15
Days Payables Outstanding			4.91
Days Inventory Outstanding			41.49
Operating Cycle			117.54
Cash Conversion Cycle			104.29
Asset Turnover			0.47

Metric
Operating Cash Flow			185.77M
Free Cash Flow			179.97M
Cash Flow to Debt			12.77
Operating Cash Flow/Sales			0.39
Free Cash Flow Yield			0.03

Metric
Cash & Equivalents			96.78M
Accounts Receivable			3.99M
Inventory
Goodwill			67.94M
Debt to Capitalization			0.02
Debt to Assets			0.01
Current Ratio			7.00
Quick Ratio			7.71

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.12
R&D to Revenue			0.19
SG&A to Revenue			0.08